BOSS Study: A Study of Fuzeon Using the Needle-Free Biojector 2000 in Patients With HIV-1 Infection
Public ClinicalTrials.gov record NCT00337701. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Biojector 2000 Open-Label Safety Study (BOSS) to Evaluate Signs and Symptoms Associated With a Needle-free Injection Device for Administration of Fuzeon to Patients With HIV-1 Infection
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study will evaluate the signs and symptoms associated with Fuzeon injection (90mg sc) using the B2000 needle-free injection device, in HIV-1 positive patients experienced to Fuzeon treatment, but having difficulty tolerating long-term (\>4 weeks) administration of Fuzeon with the standard needle and syringe. Patients will be randomized to the B2000 device or the standard needle and syringe for 4 weeks; all patients will use the B2000 device for the next 4 weeks. The anticipated time on study treatment is \<3 months, and the target sample size is 100-500 individuals.
Study identification
- NCT ID
- NCT00337701
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 326 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 16 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 2006 (Type not available)
- Primary completion
- Jan 2007 (Actual)
- Completion
- Jan 2007 (Actual)
- Last update posted
- Nov 3, 2015
2006 – 2007
United States locations
- U.S. sites
- 42
- U.S. states
- 20
- U.S. cities
- 38
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Birmingham | Alabama | 35294-2050 | — |
| Not listed | Phoenix | Arizona | 85006 | — |
| Not listed | Phoenix | Arizona | 85012 | — |
| Not listed | Fountain Valley | California | 92708 | — |
| Not listed | Hayward | California | 94545 | — |
| Not listed | Long Beach | California | 90813 | — |
| Not listed | Los Angeles | California | 90036 | — |
| Not listed | Palm Springs | California | 92262 | — |
| Not listed | San Francisco | California | 94115 | — |
| Not listed | Santa Clara | California | 95051 | — |
| Not listed | Denver | Colorado | 80220 | — |
| Not listed | Fort Lauderdale | Florida | 33316 | — |
| Not listed | Fort Myers | Florida | 33901 | — |
| Not listed | North Miami Beach | Florida | 33169 | — |
| Not listed | Orlando | Florida | 32803 | — |
| Not listed | Plantation | Florida | 33317 | — |
| Not listed | Port Saint Lucie | Florida | 34952 | — |
| Not listed | Tampa | Florida | 33614 | — |
| Not listed | Atlanta | Georgia | 30318 | — |
| Not listed | Decatur | Georgia | 30033 | — |
| Not listed | Boise | Idaho | 83704 | — |
| Not listed | Chicago | Illinois | 60657 | — |
| Not listed | Baltimore | Maryland | 21201 | — |
| Not listed | Silver Spring | Maryland | 20910 | — |
| Not listed | Boston | Massachusetts | 02215-3318 | — |
| Not listed | Berkley | Michigan | 48072-1550 | — |
| Not listed | St Louis | Missouri | 63117 | — |
| Not listed | St Louis | Missouri | 63139 | — |
| Not listed | Somers Point | New Jersey | 08244 | — |
| Not listed | Voorhees Township | New Jersey | 08043 | — |
| Not listed | New York | New York | 10011 | — |
| Not listed | New York | New York | 10016 | — |
| Not listed | Rochester | New York | 14604 | — |
| Not listed | Winston-Salem | North Carolina | 27103 | — |
| Not listed | Portland | Oregon | 97209-2534 | — |
| Not listed | Philadelphia | Pennsylvania | 19107 | — |
| Not listed | Fort Worth | Texas | 76104 | — |
| Not listed | Galveston | Texas | 77555 | — |
| Not listed | Houston | Texas | 77027 | — |
| Not listed | Houston | Texas | 77098 | — |
| Not listed | Hampton | Virginia | 23666 | — |
| Not listed | Spokane | Washington | 99204 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00337701, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 3, 2015 · Synced Oct 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00337701 live on ClinicalTrials.gov.